Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • Assessment of the 12-Lead E...
    Maron, Barry J., MD, FACC; Friedman, Richard A., MD, FACC; Kligfield, Paul, MD, FAHA; Levine, Benjamin D., MD; Viskin, Sami, MD; Chaitman, Bernard R., MD, FAHA; Okin, Peter M., MD, FAHA, FACC; Saul, J. Philip, MD, FAHA, FACC; Salberg, Lisa; Van Hare, George F., MD; Soliman, Elsayed Z., MD, FAHA, FACC; Chen, Jersey, MD, MPH; Matherne, G. Paul, MD, FAHA, FACC; Bolling, Steven F., MD, FAHA; Mitten, Matthew J., JD; Caplan, Arthur, PhD; Balady, Gary J., MD, FAHA; Thompson, Paul D., MD, FAHA, FACC

    Journal of the American College of Cardiology, 10/2014, Volume: 64, Issue: 14
    Journal Article

    New Scope of the Document Although reports on cardiovascular screening efficacy have predominantly involved populations of adolescents and young adults participating in competitive athletics, the context of the present discussion is intentionally (and necessarily) much more expansive. ...it is underscored that the present report is not limited in scope to universal mass screening for athlete populations but importantly includes considerations for screening large, young, and truly general populations (school-aged, 12-25 years old, of both sexes) with respect to relevant logistical, ethical, legal, and societal issues (e.g., in the United States or other countries or communities of various sizes, in schools, or in regional or military populations).